$0
$783,000
0.0% of portfolio
54,284
Q3 2024
Reduced 31.87%
$0
$4.46 Million
0.0% of portfolio
140,797
Q3 2024
Reduced 27.25%
$0
$1.46 Million
0.0% of portfolio
75,891
Q3 2024
Reduced 81.79%
$0
$3.92 Million
0.0% of portfolio
125,737
Q3 2024
Reduced 48.34%
$0
$1.46 Million
0.0% of portfolio
63,851
Q3 2024
Reduced 42.55%
-
$0
0.0% of portfolio
-
Q3 2024
New
$0
$2.3 Million
0.0% of portfolio
94,942
Q3 2024
Added 39.43%
-
$0
0.0% of portfolio
-
Q3 2024
Added 121.53%
$0
$255,000
0.0% of portfolio
13,611
Q3 2024
Reduced 78.44%
$3.39B
$4.23 Million
0.0% of portfolio
181,594
Q3 2024
Reduced 33.34%
$1.84B
$1.48 Million
0.0% of portfolio
137,405
Q3 2024
Reduced 17.84%
$43.3B
$5.53 Million
0.0% of portfolio
96,579
Q3 2024
Reduced 58.38%
$1.32B
$356,000
0.0% of portfolio
28,617
Q3 2024
Reduced 54.54%
$5.05B
$3.31 Million
0.0% of portfolio
18,181
Q3 2024
Reduced 76.64%
$2.75B
$3.2 Million
0.0% of portfolio
70,783
Q3 2024
Added 23.56%
$747M
$2.46 Million
0.0% of portfolio
126,085
Q3 2024
Added 36.7%
$924M
$557,000
0.0% of portfolio
6,915
Q3 2024
Reduced 80.01%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 70.58%
$2.56B
$4.19 Million
0.0% of portfolio
88,474
Q3 2024
Reduced 1.84%
$7.9B
$1.46 Million
0.0% of portfolio
63,682
Q3 2024
Reduced 63.13%
-
$0
0.0% of portfolio
-
Q3 2024
Added 78.33%
$46.9B
$410,000
0.0% of portfolio
1,727
Q3 2024
Reduced 97.88%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 37.62%
$1.94B
$4.03 Million
0.0% of portfolio
93,984
Q3 2024
Reduced 6.45%
-
$0
0.0% of portfolio
-
Q3 2024
Added 34.56%
$1.51B
$17.7 Million
0.0% of portfolio
1,528,802
Q3 2024
Added 1,089.14%
$1.89B
$2.19 Million
0.0% of portfolio
33,652
Q3 2024
Reduced 30.65%
Lakeshore Biopharma CO LTD
-
$0
0.0% of portfolio
-
Q1 2023
New
$11.6B
$990,000
0.0% of portfolio
7,415
Q3 2024
Reduced 82.15%
$11B
$7.86 Million
0.0% of portfolio
121,372
Q3 2024
Reduced 45.21%
$5.13B
$3.92 Million
0.0% of portfolio
22,178
Q3 2024
Reduced 26.74%
$439M
$203,000
0.0% of portfolio
15,332
Q3 2024
Reduced 44.64%
$472M
$708,000
0.0% of portfolio
57,393
Q3 2024
Added 40.03%
$6.69B
$898,000
0.0% of portfolio
4,754
Q3 2024
Reduced 95.79%
$6.21B
$13 Million
0.0% of portfolio
118,610
Q3 2024
Reduced 67.28%
$105M
$87,000
0.0% of portfolio
21,126
Q3 2024
Reduced 65.53%
Lanvin Group Holdings Limite
-
$0
0.0% of portfolio
-
Q3 2024
Reduced -0.0%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 23.24%
$274M
$745,000
0.0% of portfolio
113,783
Q3 2024
Added 80.15%
$39.3B
$4.43 Million
0.0% of portfolio
88,008
Q3 2024
Reduced 89.64%
$44.2M
$577,000
0.0% of portfolio
35,385
Q3 2024
New
$772M
$254,000
0.0% of portfolio
37,397
Q3 2024
Reduced 12.61%
$7.73B
$10.2 Million
0.0% of portfolio
191,937
Q3 2024
Reduced 16.33%
$0
$958,000
0.0% of portfolio
31,433
Q3 2024
Added 149.79%
-
$0
0.0% of portfolio
-
Q3 2024
New
$0
$1.23 Million
0.0% of portfolio
41,307
Q3 2024
Added 0.27%
$17.1B
$20.3 Million
0.0% of portfolio
203,958
Q3 2024
Reduced 39.9%
$3.12B
$2.87 Million
0.0% of portfolio
173,021
Q3 2024
Reduced 27.98%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 92.84%
$3.12B
$7.9 Million
0.0% of portfolio
65,520
Q3 2024
Added 91.67%